Hinge Health, Inc. 8-K

What Happened
Hinge Health, Inc. announced on March 16, 2026 (filed March 17, 2026) that its Board appointed Tyler Sloat as a Class I director, effective immediately. Mr. Sloat will serve until the 2026 annual meeting and was named Chair of the Compensation Committee and a member of the Audit Committee. He currently serves as COO of Freshworks (since Aug 2024) and was its CFO since Apr 2020; earlier he was CFO of Zuora from Sep 2010 to Apr 2020. Mr. Sloat holds a B.A. in Economics (Boston College), an MBA from Stanford GSB, and is an inactive CPA in California.

Key Details

• Appointment date: March 16, 2026; term expiring at the 2026 annual meeting.
• Initial equity grant: RSUs valued at $400,000, vesting annually over three years, subject to continued service.
• Annual cash fees (pro‑rated for 2026): $40,000 (board), $15,000 (Compensation Committee chair), $10,000 (Audit Committee); Mr. Sloat elected to receive these fees as RSUs.
• Future annual RSU award: currently valued at $200,000 beginning at the 2027 annual meeting if serving; RSUs vest in full upon a Change in Control, subject to continued service.
• No related-party transactions or family relationships reported; Company will enter its standard indemnification agreement with Mr. Sloat.

Why It Matters
This change updates Hinge Health's board composition and committee leadership ahead of the 2026 annual meeting. Investors should note the governance implications—new Compensation Committee chair—and the director compensation commitments (initial $400K RSU grant plus ongoing RSU awards and fee conversions) which affect dilution and equity expense. The filing contains no material related-party transactions tied to the appointment.